Os08g0189400 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
Os08g0189400 antibody; LOC_Os08g08990 antibody; B1099H05.29 antibody; OsJ_025244 antibody; P0610E02.5Germin-like protein 8-5 antibody
Target Names
Os08g0189400
Uniprot No.

Target Background

Function
This antibody targets a protein involved in broad-spectrum disease resistance. While possessing a conserved active site, it is unlikely to exhibit oxalate oxidase activity.
Database Links
Protein Families
Germin family
Subcellular Location
Secreted, extracellular space, apoplast.

Q&A

What is Os08g0189400 and why are antibodies against it important?

Os08g0189400 (also called GLP8-5) is a gene encoding GERMIN-LIKE PROTEIN 8-5 in rice (Oryza sativa) . It belongs to a family of proteins with roles in plant development and stress responses. Antibodies against this protein are valuable tools for:

  • Studying protein expression patterns across different rice tissues

  • Investigating protein function in stress response mechanisms

  • Examining protein-protein interactions in defense pathways

  • Validating gene expression studies at the protein level

GLP8-5 is part of a cluster of germin-like protein genes on chromosome 8, including GLP8-1 through GLP8-12, suggesting possible functional redundancy or specialization .

What types of antibodies are available for Os08g0189400 detection?

Current commercial offerings include:

  • Polyclonal antibodies: Raised in rabbits against recombinant Oryza sativa subsp. japonica Os08g0189400 protein

  • Monoclonal antibody combinations: Available as cocktails targeting different epitopes of the protein

Antibody TypeHostPurification MethodRecommended ApplicationsStorage Conditions
PolyclonalRabbitAntigen AffinityELISA, WB-20°C or -80°C in 50% glycerol, 0.01M PBS, pH 7.4 with 0.03% Proclin 300
Monoclonal CombinationsMouseVaries by manufacturerELISA (titer: ~10,000), WBCompany-specific recommendations

How can I validate the specificity of an Os08g0189400 antibody?

Validation is critical for ensuring experimental reliability. Implement the following methodological approach:

  • Western blot analysis:

    • Use positive controls (rice tissues with known Os08g0189400 expression)

    • Include negative controls (tissues with minimal expression)

    • Verify that observed band size matches predicted molecular weight

    • Test antibody against recombinant Os08g0189400 protein

  • Immunodepletion assays:

    • Pre-incubate antibody with purified antigen

    • Compare binding of depleted vs. non-depleted antibody

    • Significant signal reduction confirms specificity

  • Cross-reactivity assessment:

    • Test against related germin-like proteins (GLP8-1 through GLP8-12)

    • Determine specificity within the GLP family

This multi-faceted approach follows validation principles similar to those used in therapeutic antibody development .

What are the optimal protocols for Western blotting with Os08g0189400 antibodies?

Based on methodological approaches established for plant protein detection:

  • Sample preparation:

    • Grind rice tissue in liquid nitrogen

    • Extract proteins using buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, protease inhibitors

    • Clarify by centrifugation (14,000g, 15 min, 4°C)

  • Gel electrophoresis parameters:

    • Load 20-40μg protein per lane

    • Use 12-15% SDS-PAGE (germin-like proteins are typically ~20-25kDa)

  • Transfer and detection optimization:

    • Transfer to PVDF membrane (100V, 60 minutes)

    • Block with 5% non-fat milk in TBST (1 hour, room temperature)

    • Primary antibody incubation: 1:1000 dilution (optimize as needed), overnight at 4°C

    • Wash 3× with TBST

    • Secondary antibody: 1:5000 HRP-conjugated anti-rabbit IgG, 1 hour at room temperature

    • Visualize using ECL substrate

  • Troubleshooting guidance:

    • For weak signal: Increase antibody concentration or extend incubation time

    • For high background: Increase blocking stringency or add 0.1% Tween-20 to antibody dilution

How should I design immunoprecipitation experiments with Os08g0189400 antibodies?

For successful immunoprecipitation of Os08g0189400:

  • Lysate preparation:

    • Extract proteins in mild lysis buffer: 50mM Tris-HCl (pH 7.5), 150mM NaCl, 0.5% NP-40, protease inhibitors

    • Clear lysate by centrifugation (14,000g, 15 min, 4°C)

    • Pre-clear with Protein A/G beads to reduce non-specific binding

  • Immunoprecipitation protocol:

    • Add 2-5μg antibody to 500μg-1mg protein lysate

    • Incubate with rotation overnight at 4°C

    • Add 30μl Protein A/G beads, incubate 2-4 hours

    • Wash 4× with cold lysis buffer

    • Elute with 2× Laemmli buffer and analyze by Western blot

  • Controls to include:

    • Input sample (5-10% of starting material)

    • Negative control (non-specific IgG from same species)

    • Beads-only control (no antibody)

This approach is adapted from antibody-dependent immunoprecipitation methods used in similar plant protein studies .

How can Os08g0189400 antibodies be utilized in studying plant stress responses?

Germin-like proteins are implicated in biotic and abiotic stress responses. Methodological approaches include:

  • Expression profiling across stress conditions:

    • Subject rice plants to various stresses (drought, salt, pathogen infection)

    • Collect tissue samples at defined time points

    • Use Western blotting with Os08g0189400 antibodies to track protein accumulation

    • Correlate protein levels with stress phenotypes and gene expression data

  • Tissue-specific localization:

    • Perform immunohistochemistry on plant sections

    • Use confocal microscopy with fluorescently-labeled secondary antibodies

    • Document tissue-specific accumulation patterns during stress responses

  • Protein complex analysis:

    • Conduct co-immunoprecipitation under stress conditions

    • Identify interacting partners by mass spectrometry

    • Verify interactions with reciprocal co-IP experiments

These approaches leverage antibody-based methods similar to those used in studying immune responses, where protein interactions and expression changes are critical to understanding biological function .

What considerations are important when using Os08g0189400 antibodies for quantitative analysis?

For accurate quantitative assessments:

  • Standard curve establishment:

    • Use purified recombinant Os08g0189400 protein at known concentrations

    • Generate standard curves in every experiment

    • Ensure linearity within your working range

  • Sample normalization strategies:

    • Always include housekeeping protein controls (e.g., actin, tubulin)

    • Normalize target protein signal to loading control

    • Consider total protein normalization using stain-free gels

  • Statistical considerations:

    • Run at least three biological replicates

    • Apply appropriate statistical tests

    • Report variability (standard deviation or standard error)

  • Technical validation:

    • Confirm antibody binding is proportional to protein concentration

    • Verify signal is within linear detection range of your imaging system

    • Use multiple antibody dilutions to establish optimal working range

This methodological approach follows quantitative principles established for antibody-based protein detection .

How does the antibody distinguish Os08g0189400 from other germin-like proteins?

This represents a significant challenge due to sequence similarity within the germin-like protein family. Consider these methodological approaches:

  • Epitope mapping:

    • Identify the precise epitope recognized by the antibody

    • Compare epitope sequence across GLP family members

    • Predict potential cross-reactivity based on sequence conservation

  • Experimental cross-reactivity assessment:

    • Test antibody against recombinant versions of GLP8-1 through GLP8-12

    • Create a cross-reactivity profile table (example below)

    • Consider competitive binding assays to quantify relative affinities

GLP Family MemberSequence Identity to GLP8-5 (%)Cross-Reactivity Level
GLP8-1 (Os08g0188900)~85-90% (predicted)Strong
GLP8-2 (Os08g0189100)~80-85% (predicted)Moderate
GLP8-3 (Os08g0189200)~75-80% (predicted)Weak
GLP8-6 (Os08g0189500)~90-95% (predicted)Strong
  • Validation in knockout/knockdown lines:

    • Test antibody specificity in lines where Os08g0189400 expression is eliminated

    • Any remaining signal indicates cross-reactivity with other proteins

This approach is similar to specificity testing conducted for therapeutic antibodies where distinguishing between closely related targets is critical .

What strategies can minimize cross-reactivity issues in experimental design?

Implement these methodological approaches:

  • Antibody pre-adsorption:

    • Pre-incubate antibody with recombinant proteins of related GLPs

    • Remove cross-reactive antibodies by affinity depletion

    • Use the depleted antibody preparation for higher specificity

  • Epitope-targeted antibody design:

    • Identify unique regions in Os08g0189400 sequence

    • Generate antibodies against these unique epitopes

    • Validate specificity against the entire GLP family

  • Complementary approaches:

    • Confirm antibody findings with orthogonal methods (mass spectrometry)

    • Correlate protein detection with gene expression data

    • Use genetic tools (CRISPR, RNAi) to verify antibody specificity

These approaches are adapted from established methods for ensuring antibody specificity in complex biological systems .

How should I analyze contradictory results between antibody detection and transcript levels?

Protein and mRNA levels often show poor correlation. Address discrepancies through:

  • Systematic troubleshooting:

    • Verify antibody specificity under your specific conditions

    • Confirm primer specificity for transcript detection

    • Check for post-transcriptional regulation mechanisms

  • Biological explanation exploration:

    • Investigate protein stability and half-life

    • Examine post-translational modifications affecting antibody recognition

    • Consider tissue-specific translation efficiency differences

  • Integrated data analysis approach:

    • Incorporate temporal dynamics (protein expression may lag behind transcription)

    • Analyze subcellular fractionation (protein may be compartmentalized)

    • Examine protein complex formation (affecting epitope accessibility)

  • Statistical framework:

    • Apply correlation analysis between protein and mRNA levels

    • Identify consistent patterns across experimental conditions

    • Use multiple time points to track expression dynamics

This approach acknowledges the complex relationship between transcription and translation, similar to investigations in immunology where antibody responses don't always correlate with antigen levels .

What statistical methods are appropriate for antibody-based quantification of Os08g0189400?

For robust quantitative analysis:

  • Replicate structure design:

    • Minimum three biological replicates

    • Two or more technical replicates per biological sample

    • Include inter-assay calibration samples

  • Normalization methods:

    • Reference protein normalization (housekeeping proteins)

    • Total protein normalization

    • Consideration of matrix effects

  • Statistical approaches:

    • For comparing two conditions: t-test with appropriate corrections

    • For multiple conditions: ANOVA with post-hoc tests

    • For time-course data: repeated measures ANOVA or mixed-effects models

  • Reporting standards:

    • Include error bars (standard deviation or standard error)

    • Report p-values and significance thresholds

    • Provide raw data availability statement

This framework ensures statistical rigor similar to approaches used in quantitative antibody studies in other fields .

How can I develop improved antibodies against Os08g0189400 using structure-based design?

Advanced antibody engineering approaches include:

  • Structural analysis for epitope selection:

    • Predict Os08g0189400 tertiary structure using homology modeling

    • Identify surface-exposed, unique regions as epitope candidates

    • Select epitopes that distinguish Os08g0189400 from other GLPs

  • Antibody library design strategy:

    • Generate synthetic antibody libraries targeting specific epitopes

    • Screen libraries using phage display technology

    • Select candidates based on affinity and specificity metrics

  • Affinity maturation methodology:

    • Introduce targeted mutations in complementarity-determining regions

    • Screen for improved binding using yeast or phage display

    • Validate improvements through binding kinetics analysis

This approach adapts methods used in therapeutic antibody development, where structure-based design has yielded highly specific antibodies against challenging targets .

What are considerations for utilizing Os08g0189400 antibodies across different rice varieties?

Sequence variation between rice varieties can affect antibody recognition. Address this through:

  • Sequence analysis across rice varieties:

    • Compare Os08g0189400 sequences from multiple rice cultivars

    • Identify conserved regions for universal detection

    • Map sequence variations to antibody epitopes

  • Validation in multiple varieties:

    • Test antibody performance in japonica and indica varieties

    • Verify detection in wild rice relatives if relevant

    • Document any variety-specific detection limitations

  • Calibration curve adjustments:

    • Develop variety-specific standard curves if necessary

    • Use recombinant protein standards representing specific varieties

    • Apply correction factors for cross-variety comparisons

This approach recognizes the genetic diversity within rice species and ensures experimental validity across different research materials .

How can machine learning approaches enhance Os08g0189400 antibody design and applications?

Integrating computational methods can advance antibody research:

  • Epitope prediction optimization:

    • Apply deep learning models to predict optimal epitopes

    • Identify regions with maximal specificity and accessibility

    • Integrate structural information to improve prediction accuracy

  • Antibody-antigen binding prediction:

    • Use library-on-library screening approaches to generate training data

    • Develop machine learning models to predict binding affinity

    • Apply active learning strategies to improve prediction accuracy with minimal experimental data

  • Cross-reactivity prediction framework:

    • Train models on existing antibody cross-reactivity data

    • Predict potential off-target binding within the GLP family

    • Guide experimental validation of predicted cross-reactivity

This approach leverages recent advances in computational antibody science, where machine learning has significantly improved antibody design and performance prediction .

What methodological considerations are important when using Os08g0189400 antibodies in multiplex detection systems?

For simultaneous detection of multiple proteins:

  • Antibody labeling strategies:

    • Select compatible fluorophores with minimal spectral overlap

    • Optimize signal-to-noise ratio for each antibody

    • Verify that labeling doesn't affect binding properties

  • Multiplex assay development:

    • Test for antibody cross-reactivity in multiplex format

    • Establish detection limits for each target

    • Validate quantification across dynamic range

  • Data analysis considerations:

    • Apply spectral unmixing algorithms where necessary

    • Account for channel bleed-through in quantification

    • Develop appropriate normalization strategies for multiplex data

This methodological framework adapts approaches from immunological research where multiplex antibody assays are routinely employed .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.